Most studies in both murine lupus models and humans have equated lupus nephritis (LN) with glomerulonephritis (GN). However, tubulointerstitial inflammation (Tl) on renal biopsy, independently of GN, is a strong predictor of subsequent renal failure. Mechanistic investigations have demonstrated that GN results from a systemic break in B cell tolerance and the local deposition of immune complexes containing antibodies reactive with ubiquitous self-antigens. We now provide evidence that Tl results from a fundamentally different pathogenic mechanism than GN. In most patients with severe Tl, the inflammatory infiltrate is organized into either well-circumscribed T:B cell aggregates or germinal centers (GCs) containing follicular dendritic cells. The presence of these lymphoid like structures on renal biopsy (tertiary lymphoid neogenesis, TLN) was strongly associated with deposition of immune complexes in tubular basement membranes (TBM). Subsequent sampling of in situ expressed immunoglobulins revealed a restricted repertoire in both GC and T:B aggregates consistent with local clonal selection. Expression and functional characterization of a predominant in situ selected antibody (GC-1) from a renal germinal center revealed specific reactivity with distal tubular epithelial cells and tubular basement membrane immune complexes. The GC-1 antibody did not react with normal renal tissue, normal or hepatitis C liver biopsies or even renal biopsies from patients with non-lupus interstitial nephritis. Based on these and other findings described in Preliminary Results, we propose that LIN is a manifestation of in situ autoimmunity and a break in tolerance to antigens specifically expressed in the tubulointerstitium of patients with LIN. This model will be tested in the following Specific Aims:
Aim 1. To functionally characterize the in situ immunoglobulin in repertoire in LIN.
Aim 2. To identify organ-specific autoantigens in LIN.
The goal of this research project is to determine how in situ immune responses contribute to the pathogenesis of human lupus nephritis. These investigations may lead to either new diagnostic tests for lupus nephritis or to identifying new therapeutic targets. Therefore, the proposed studies are of high relevance to the management of patients with lupus.
|Rivas, Jacqueline R; Ireland, Sara J; Chkheidze, Rati et al. (2017) Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients. Acta Neuropathol 133:43-60|
|Neu, Karlynn E; Tang, Qingming; Wilson, Patrick C et al. (2017) Single-Cell Genomics: Approaches and Utility in Immunology. Trends Immunol 38:140-149|
|He, Wenqian; Tan, Gene S; Mullarkey, Caitlin E et al. (2016) Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus. Proc Natl Acad Sci U S A 113:11931-11936|
|Henault, Jill; Riggs, Jeffrey M; Karnell, Jodi L et al. (2016) Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol 17:196-203|
|Jardine, Joseph G; Sok, Devin; Julien, Jean-Philippe et al. (2016) Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. PLoS Pathog 12:e1005905|
|Lee, Jiwon; Boutz, Daniel R; Chromikova, Veronika et al. (2016) Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat Med 22:1456-1464|
|Ko, Kichul; Wang, Jianing; Perper, Stuart et al. (2016) Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation. Arthritis Rheumatol 68:2740-2751|
|Trotter, Kimberly; Clark, Marcus R; Liarski, Vladimir M (2016) Overview of pathophysiology and treatment of human lupus nephritis. Curr Opin Rheumatol 28:460-7|
|Canzar, Stefan; Neu, Karlynn E; Tang, Qingming et al. (2016) BASIC: BCR assembly from single cells. Bioinformatics :|
|DiLillo, David J; Palese, Peter; Wilson, Patrick C et al. (2016) Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J Clin Invest 126:605-10|
Showing the most recent 10 out of 40 publications